Becton Dickinson (BDX) Enterprise Value (2009 - 2026)
Becton Dickinson's (BDX) quarterly Enterprise Value came in at -$816.0 million in Q1 2026, down 9.24% year-on-year from -$899.0 million in Q1 2025, and down 8.66% on a QoQ basis from -$751.0 million in Q4 2025.
Becton Dickinson (BDX) Enterprise Value (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Enterprise Value data on file, last reported at -$816.0 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 9.24% year-over-year to -$816.0 million in Q1 2026; TTM through Mar 2026 was -$816.0 million, a 9.24% decrease from a year earlier, with the FY2025 full-year figure at -$575.0 million, up 69.02% from the prior year.
- Enterprise Value for Q1 2026 stood at -$816.0 million, down from -$751.0 million in the prior quarter.
- Over the last five years, Enterprise Value for BDX reached as high as -$575.0 million in Q3 2025 and fell as low as -$5.3 billion in Q2 2024.
- Historically, Enterprise Value has averaged -$1.6 billion across 5 years, with a median of -$1.2 billion in 2022.
- Across the five-year window, Enterprise Value sank 418.55% in 2024 and soared 84.99% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$612.0 million in 2022, then slumped by 93.14% to -$1.2 billion in 2023, then jumped by 38.41% to -$728.0 million in 2024, then retreated by 3.16% to -$751.0 million in 2025, then declined by 8.66% to -$816.0 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$816.0 million in Q1 2026, -$751.0 million in Q4 2025, and -$575.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -1.66 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -5.09 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -816.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 5.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -1.66 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -435.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -138.60 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -561.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -1.06 Bn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | -2.04 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -816.00 Mn |
| Dec 31, 2025 | -751.00 Mn |
| Sep 30, 2025 | -575.00 Mn |
| Jun 30, 2025 | -797.00 Mn |
| Mar 31, 2025 | -747.00 Mn |
| Dec 31, 2024 | -728.00 Mn |
| Sep 30, 2024 | -1.86 Bn |
| Jun 30, 2024 | -5.31 Bn |
| Mar 31, 2024 | -2.39 Bn |
| Dec 31, 2023 | -1.18 Bn |
| Sep 30, 2023 | -1.48 Bn |
| Jun 30, 2023 | -1.02 Bn |
| Mar 31, 2023 | -1.99 Bn |
| Dec 31, 2022 | -612.00 Mn |
| Sep 30, 2022 | -1.16 Bn |
| Jun 30, 2022 | -2.76 Bn |
| Mar 31, 2022 | -3.32 Bn |
| Dec 31, 2021 | -2.05 Bn |
| Sep 30, 2021 | -2.39 Bn |
| Jun 30, 2021 | -3.18 Bn |